The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
TR4: Inhibitor of notch activation.
A. A. Epenetos
Employment or Leadership Position - Trojantec
C. Kousparou
Employment or Leadership Position - Trojantec
Stock Ownership - Trojantec
S. Stylianou
Employment or Leadership Position - Trojantec
M. Deonarain
Consultant or Advisory Role - Trojantec